Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioparts is a Brazilian medical technology company specializing in the development and manufacture of customized surgical implants and anatomical biomodels. Utilizing advanced 3D printing and additive manufacturing technologies, the company produces patient-specific solutions for complex surgeries in fields such as neurosurgery, orthopedics, and oral and maxillofacial surgery. Their product portfolio includes custom titanium implants, surgical guides, and high-fidelity anatomical models used for preoperative planning. Bioparts aims to improve surgical precision and patient outcomes through personalized medical devices that are tailored to the unique anatomy of each patient.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Empresa Bioparts do Brasil Suprimentos Cirúrgicos e Hospitalares.